Pancreatitis Trial, Recruiting (NCT04037007)

Pancreatitis Trial, Recruiting NCT04037007 Sponsor: Coordinación de Investigación en Salud, Mexico Condition: Pancreatitis

Printed from Voxsanity (voxsanity.com.au) — NCT04037007 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are scheduled to have a procedure called ERCP (a procedure that examines the bile ducts using a flexible camera) and your doctor suspects or has confirmed you have gallstones in the bile duct, a narrowing of the bile duct (whether due to cancer or a non-cancerous cause).

Who may not be able to join:

You have had an ERCP procedure before
Your stomach or small intestine has been altered by previous surgery
Your doctor suspects or has confirmed a growth or tumour near the opening of the bile duct (the ampulla)
You have been diagnosed with cancer of the small intestine (duodenum)
You have certain types of small pouches (called diverticula) near the bile duct opening (types 1 and 2) (confirm with trial site)
You are pregnant
Your blood does not clot properly, specifically if a measurement called INR is higher than 1.5 (a blood test your doctor can check)

Who may be removed from the trial after joining:

If the procedure cannot be completed due to a problem related to the anaesthetic (the medication used to keep you comfortable during the procedure)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Oscar V Hernandez Mondragon, MD, Instituto Mexicano del Seguro Social

Phone: +525556276900

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04037007

Sponsor: Coordinación de Investigación en Salud, Mexico

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatitis

Trial contact: +525556276900

More information: https://clinicaltrials.gov/study/NCT04037007

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are scheduled to have a procedure called ERCP (a procedure that examines the bile ducts using a flexible camera) and your doctor suspects or has confirmed you have gallstones in the bile duct, a narrowing of the bile duct (whether due to cancer or a non-cancerous cause).

Who may not be able to join:

You have had an ERCP procedure before
Your stomach or small intestine has been altered by previous surgery
Your doctor suspects or has confirmed a growth or tumour near the opening of the bile duct (the ampulla)
You have been diagnosed with cancer of the small intestine (duodenum)
You have certain types of small pouches (called diverticula) near the bile duct opening (types 1 and 2) (confirm with trial site)
You are pregnant
Your blood does not clot properly, specifically if a measurement called INR is higher than 1.5 (a blood test your doctor can check)

Who may be removed from the trial after joining:

If the procedure cannot be completed due to a problem related to the anaesthetic (the medication used to keep you comfortable during the procedure)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Coordinación de Investigación en Salud, Mexico

Registry

ClinicalTrials.gov

Start date

3 July 2019

Est. completion

1 December 2026

Where this trial is recruiting

🇲🇽 Mexico

Primary endpoints

Cannulation success rate within 5 minutes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov